China Shineway Pharmaceutical Group Limited (C1S) — Cash Flow Quality Index
China Shineway Pharmaceutical Group Limited (C1S) has a Cash Flow Quality Index of 0.65x as of June 2023. Operating cash flow of €160.69 Million is below net income of €245.73 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore C1S operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China Shineway Pharmaceutical Group Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for China Shineway Pharmaceutical Group Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does China Shineway Pharmaceutical Group Limi generate cash.
Annual Cash Flow Quality Index for China Shineway Pharmaceutical Group Limited (2013–2025)
Year-by-year earnings quality comparison for China Shineway Pharmaceutical Group Limited.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.23x | €1.17 Billion | €949.95 Million | ▲ +7.6% |
| 2024 | 1.15x | €963.13 Million | €840.05 Million | ▲ +19.2% |
| 2023 | 0.96x | €932.63 Million | €969.51 Million | ▼ -37.3% |
| 2022 | 1.54x | €1.11 Billion | €722.77 Million | ▲ +21.5% |
| 2021 | 1.26x | €703.15 Million | €556.67 Million | ▼ -41.6% |
| 2020 | 2.16x | €638.57 Million | €295.03 Million | ▲ +195.9% |
| 2019 | 0.73x | €368.00 Million | €503.15 Million | ▼ -30.5% |
| 2018 | 1.05x | €532.59 Million | €505.88 Million | ▼ -3.1% |
| 2017 | 1.09x | €490.65 Million | €451.55 Million | ▼ -12.7% |
| 2016 | 1.24x | €733.53 Million | €589.20 Million | ▲ +10.0% |
| 2015 | 1.13x | €744.71 Million | €657.91 Million | ▲ +3.2% |
| 2014 | 1.10x | €773.16 Million | €704.77 Million | ▲ +44.3% |
| 2013 | 0.76x | €519.89 Million | €683.65 Million | — |